Cholangiocytes and primary biliary cirrhosis: prediction and predication.
Gershwin
M E
ME
Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, California 95616, USA. megershwin@ucdavis.edu
Van de Water
J
J
D000217:Acyltransferases / Q000737:chemistry / Q000276:immunology; D000818:Animals; D017209:Apoptosis / Q000276:immunology; D001324:Autoantigens / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism; D001652:Bile Ducts / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D001665:Binding Sites; D002460:Cell Line; D051047:Dihydrolipoyllysine-Residue Acetyltransferase; D004847:Epithelial Cells / Q000276:immunology; D005786:Gene Expression Regulation; D019254:Genes, bcl-2; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D008928:Mitochondria / Q000276:immunology; D011768:Pyruvate Dehydrogenase Complex / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism; D051381:Rats; D014162:Transfection
D001324:Autoantigens; D011768:Pyruvate Dehydrogenase Complex; D000217:Acyltransferases; C033588:dihydrolipoamide acyltransferase; D051047:Dihydrolipoyllysine-Residue Acetyltransferase; C021515:dihydrolipoamide succinyltransferase; D005978:Glutathione